These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19521976)

  • 1. New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells.
    Miklán Z; Orbán E; Csík G; Schlosser G; Magyar A; Hudecz F
    Biopolymers; 2009; 92(6):489-501. PubMed ID: 19521976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro.
    Orbán E; Manea M; Marquadt A; Bánóczi Z; Csík G; Fellinger E; Bosze S; Hudecz F
    Bioconjug Chem; 2011 Oct; 22(10):2154-65. PubMed ID: 21950465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antitumor effect of vinblastine derivative-oligoarginine conjugates.
    Bánóczi Z; Gorka-Kereskényi Á; Reményi J; Orbán E; Hazai L; Tökési N; Oláh J; Ovádi J; Béni Z; Háda V; Szántay C; Hudecz F; Kalaus G; Szántay C
    Bioconjug Chem; 2010 Nov; 21(11):1948-55. PubMed ID: 20973492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunomycin-polypeptide conjugates with antitumor activity.
    Szabó R; Bánóczi Z; Mezo G; Láng O; Kohidai L; Hudecz F
    Biochim Biophys Acta; 2010 Dec; 1798(12):2209-16. PubMed ID: 20659420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells.
    Miklán Z; Orbán E; Bánóczi Z; Hudecz F
    J Pept Sci; 2011 Dec; 17(12):805-11. PubMed ID: 22076954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vivo antitumour effect of daunorubicin-GnRH-III derivative conjugates on colon carcinoma-bearing mice.
    Manea M; Tóvári J; Tejeda M; Schulcz A; Kapuvári B; Vincze B; Mezo G
    Anticancer Drugs; 2012 Jan; 23(1):90-7. PubMed ID: 21915040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ferrocene containing peptide conjugates: synthesis and effect on human leukemia (HL-60) cells.
    Miklán Z; Szabó R; Zsoldos-Mády V; Reményi J; Bánóczi Z; Hudecz F
    Biopolymers; 2007; 88(2):108-14. PubMed ID: 17266125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.
    Szabó I; Manea M; Orbán E; Csámpai A; Bosze S; Szabó R; Tejeda M; Gaál D; Kapuvári B; Przybylski M; Hudecz F; Mezo G
    Bioconjug Chem; 2009 Apr; 20(4):656-65. PubMed ID: 19296605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
    Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
    Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
    Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wang B; Wu M; Perchellet EM; McIlvain CJ; Sperfslage BJ; Huang X; Tamura M; Stephany HA; Hua DH; Perchellet JP
    Int J Oncol; 2001 Dec; 19(6):1169-78. PubMed ID: 11713586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Satyamoorthy K; Perchellet JP
    Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
    Etrych T; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
    Schlage P; Mezo G; Orbán E; Bosze S; Manea M
    J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
    Manea M; Leurs U; Orbán E; Baranyai Z; Öhlschläger P; Marquardt A; Schulcz Á; Tejeda M; Kapuvári B; Tóvári J; Mezo G
    Bioconjug Chem; 2011 Jul; 22(7):1320-9. PubMed ID: 21668011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments.
    Krauss U; Kratz F; Beck-Sickinger AG
    J Mol Recognit; 2003; 16(5):280-7. PubMed ID: 14523941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
    Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
    Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
    Hegedüs R; Manea M; Orbán E; Szabó I; Kiss E; Sipos E; Halmos G; Mező G
    Eur J Med Chem; 2012 Oct; 56():155-65. PubMed ID: 22967796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.